Figure 1.
Overview of treatment of the 80 anaplastic lymphoma kinase (ALK)‐positive lung adenocarcinoma patients. CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease; WBRT, whole‐brain radiotherapy.
Overview of treatment of the 80 anaplastic lymphoma kinase (ALK)‐positive lung adenocarcinoma patients. CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease; WBRT, whole‐brain radiotherapy.